TARS- Tarsus Pharmaceuticals, Inc.

Insider activity in TARS over the last quarter tilts toward selling: insiders offloaded a net 62,595 shares worth roughly $5.2M.

TARS sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Azamian Bobak R.	828.0K	$75.57M	-
Dir	Link William J Phd	95.3K	$7.47M	-
COO	Neervannan Seshadri	78.5K	$6.68M	-
Other	Wahl Bryan	64.0K	$4.29M	-
Other	Mottiwala Aziz	61.5K	$4.12M	-

Buys and sells only

10 filings · page 14

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 8, 2021	Mottiwala Aziz51	Chief Commercial Officer	Sell	1,889	$28.11	$53,099.79	-3.6%	-38.9%	-35.6%
Nov 5, 2021	Mottiwala Aziz51	Chief Commercial Officer	Sell	111	$28.04	$3,112.21	-0.2%	-39.2%	-35.5%
Nov 2, 2021	Mottiwala Aziz51	Chief Commercial Officer	Sell	6,000	$26.78	$160,690.36	-10.3%	-24.8%	-34.6%
Nov 1, 2021	Azamian Bobak R.45	President And CEO	Sell	5,833	$27.82	$162,284.08	-0.5%	-29.0%	-36.6%
Nov 1, 2021	Ackermann Michael76	Director	Sell	5,833	$27.82	$162,289.06	-0.5%	-29.0%	-36.6%
Oct 12, 2021	Azamian Bobak R.45	President And CEO	Sell	5,531	$26.30	$145,448.29	-0.5%	-17.3%	-39.1%
Oct 12, 2021	Ackermann Michael76	Director	Sell	5,633	$26.27	$147,999.61	-0.5%	-17.3%	-39.1%
Oct 8, 2021	Azamian Bobak R.45	President And CEO	Sell	302	$25.02	$7,555.44	-	-7.0%	-32.2%
Oct 8, 2021	Ackermann Michael76	Director	Sell	200	$25.03	$5,006.00	-	-7.0%	-32.2%
Sep 10, 2021	Mottiwala Aziz51	Chief Commercial Officer	Sale+OE	2,593	$22.15	$57,434.95	-4.3%	+8.2%	-27.8%